Becker's Healthcare March 7, 2024
The updated COVID-19 shots that rolled out in fall 2023 reduced the risk of severe infection by 31% in adults over 65 and immunocompromised individuals, according to data published March 4 by Cleveland Clinic researchers in Lancet Infectious Diseases.
Antivirals like nirmatrelvir and molnupiravi and the most recent COVID-19 vaccines both “significantly lowered the likelihood of hospitalization and death from currently circulating COVID-19 variants,” in the study that included 27,000 patients who tested positive for COVID-19, according to a March 6 news release.
The antivirals reduced the risk...